151 related articles for article (PubMed ID: 18434301)
1. Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function.
Uddin MN; Horvat D; Glaser SS; Mitchell BM; Puschett JB
J Biol Chem; 2008 Jun; 283(26):17946-53. PubMed ID: 18434301
[TBL] [Abstract][Full Text] [Related]
2. Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells.
Uddin MN; Horvat D; Glaser SS; Danchuk S; Mitchell BM; Sullivan DE; Morris CA; Puschett JB
Placenta; 2008 Mar; 29(3):266-73. PubMed ID: 18279954
[TBL] [Abstract][Full Text] [Related]
3. Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling.
Uddin MN; Horvat D; Childs EW; Puschett JB
Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1726-34. PubMed ID: 19386984
[TBL] [Abstract][Full Text] [Related]
4. Cinobufotalin impedes Sw.71 cytotrophoblast cell line function via cell cycle arrest and apoptotic signaling.
Afroze SH; Sloan J; Osuji GC; Drever N; Pilkinton K; Zawieja DC; Kuehl TJ; Nasir Uddin M
Mol Cell Biochem; 2016 Nov; 422(1-2):189-196. PubMed ID: 27699589
[TBL] [Abstract][Full Text] [Related]
5. Marinobufagenin impairs first trimester cytotrophoblast differentiation.
LaMarca HL; Morris CA; Pettit GR; Nagowa T; Puschett JB
Placenta; 2006; 27(9-10):984-8. PubMed ID: 16458353
[TBL] [Abstract][Full Text] [Related]
6. Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia.
Uddin MN; Horvat D; Demorrow S; Agunanne E; Puschett JB
Biochim Biophys Acta; 2011 Jan; 1812(1):49-58. PubMed ID: 20851181
[TBL] [Abstract][Full Text] [Related]
7. Cardiotonic steroids induce anti-angiogenic and anti-proliferative profiles in first trimester extravillous cytotrophoblast cells.
Ehrig JC; Horvat D; Allen SR; Jones RO; Kuehl TJ; Uddin MN
Placenta; 2014 Nov; 35(11):932-6. PubMed ID: 25149386
[TBL] [Abstract][Full Text] [Related]
8. Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.
Liu C; Bai Y; Chen Y; Wang Y; Sottejeau Y; Liu L; Li X; Lingrel JB; Malhotra D; Cooper CJ; Shapiro JI; Xie ZJ; Tian J
J Biol Chem; 2012 May; 287(20):16390-8. PubMed ID: 22451662
[TBL] [Abstract][Full Text] [Related]
9. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
10. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.
Wansapura AN; Lasko V; Xie Z; Fedorova OV; Bagrov AY; Lingrel JB; Lorenz JN
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1833-9. PubMed ID: 19376809
[TBL] [Abstract][Full Text] [Related]
11. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
12. Ouabain and Marinobufagenin: Physiological Effects on Human Epithelial and Endothelial Cells.
Klimanova EA; Fedorov DA; Sidorenko SV; Abramicheva PA; Lopina OD; Orlov SN
Biochemistry (Mosc); 2020 Apr; 85(4):507-515. PubMed ID: 32569558
[TBL] [Abstract][Full Text] [Related]
13. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
Fedorova OV; Dorofeeva NA; Lopatin DA; Lakatta EG; Bagrov AY
Hypertension; 2002 Feb; 39(2):298-302. PubMed ID: 11847201
[TBL] [Abstract][Full Text] [Related]
14. Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling-mediated mitochondrial apoptotic pathway.
Lan YL; Wang X; Lou JC; Xing JS; Zou S; Yu ZL; Ma XC; Wang H; Zhang B
Cancer Med; 2018 May; 7(5):2034-2047. PubMed ID: 29582577
[TBL] [Abstract][Full Text] [Related]
15. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
[TBL] [Abstract][Full Text] [Related]
16. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
17. Comparative Action of Cardiotonic Steroids on Intracellular Processes in Rat Cortical Neurons.
Lopachev AV; Lopacheva OM; Nikiforova KA; Filimonov IS; Fedorova TN; Akkuratov EE
Biochemistry (Mosc); 2018 Feb; 83(2):140-151. PubMed ID: 29618300
[TBL] [Abstract][Full Text] [Related]
18. A p38 mitogen-activated protein kinase inhibitor attenuates cardiotonic steroids-induced apoptotic and stress signaling in a Sw-71 cytotrophoblast cell line.
Ehrig JC; Afroze SH; Reyes M; Allen SR; Drever NS; Pilkinton KA; Kuehl TJ; Uddin MN
Placenta; 2015 Nov; 36(11):1276-82. PubMed ID: 26360379
[TBL] [Abstract][Full Text] [Related]
19. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
[TBL] [Abstract][Full Text] [Related]
20. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
